Bank stocks have had a solid January, and regional-bank stocks, and the ETF, look set to rise for the rest of the year.

Pacira BioSciences (PCRX) stock was upgraded by Truist based on a potential settlement to its patent dispute with eVenus ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

Truist Financial analyst Michael Ciarmoli reiterated a Buy rating on Northrop Grumman (NOC – Research Report) today. The company’s shares ...

In a report released today, Youssef Squali from Truist Financial reiterated a Buy rating on Integral Ad Science (IAS – Research Report). The ...

Fintel reports that on January 30, 2025, Truist Securities upgraded their outlook for Pacira BioSciences (NasdaqGS:PCRX) from ...

Regional President Travis Rhodes said Charlotte-based Truist is on the rise locally with the decision to host this spring's ...

Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's quarterly adjusted net income available to common shareholders was $1.21 ...

Geneos Wealth Management Inc. boosted its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 3.2% in the ...

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced challenges.

Truist Financial Corp. continued to settle into its trimmer fee-income strategy during the fourth quarter by slightly ...